Global Tuberculosis (TB) Diagnostics Market Research Report 2026(Status and Outlook)

February 2026 | 142 pages | ID: GC19B8617227EN
Bosson Research

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO?s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X?ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives?such as universal healthcare coverage and integrated respiratory disease programs?has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms?especially in remote rural areas?also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

The global Tuberculosis (TB) Diagnostics market size was estimated at USD 3070.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Tuberculosis (TB) Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Tuberculosis (TB) Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tuberculosis (TB) Diagnostics market.

Global Tuberculosis (TB) Diagnostics Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec

Market Segmentation (by Type)

Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others

Market Segmentation (by Application)

Diagnostic Laboratories
Hospitals

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tuberculosis (TB) Diagnostics Market
Overview of the regional outlook of the Tuberculosis (TB) Diagnostics Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tuberculosis (TB) Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Tuberculosis (TB) Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Tuberculosis (TB) Diagnostics
1.2 Key Market Segments
  1.2.1 Tuberculosis (TB) Diagnostics Segment by Type
  1.2.2 Tuberculosis (TB) Diagnostics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 TUBERCULOSIS (TB) DIAGNOSTICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Tuberculosis (TB) Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Tuberculosis (TB) Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Tuberculosis (TB) Diagnostics Product Life Cycle
3.3 Global Tuberculosis (TB) Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tuberculosis (TB) Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tuberculosis (TB) Diagnostics Market Competitive Situation and Trends
  3.8.1 Tuberculosis (TB) Diagnostics Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Tuberculosis (TB) Diagnostics Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 TUBERCULOSIS (TB) DIAGNOSTICS INDUSTRY CHAIN ANALYSIS

4.1 Tuberculosis (TB) Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF TUBERCULOSIS (TB) DIAGNOSTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Tuberculosis (TB) Diagnostics Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Tuberculosis (TB) Diagnostics Market
5.7 ESG Ratings of Leading Companies

6 TUBERCULOSIS (TB) DIAGNOSTICS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tuberculosis (TB) Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.4 Global Tuberculosis (TB) Diagnostics Price by Type (2020-2025)

7 TUBERCULOSIS (TB) DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tuberculosis (TB) Diagnostics Market Sales by Application (2020-2025)
7.3 Global Tuberculosis (TB) Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Tuberculosis (TB) Diagnostics Sales Growth Rate by Application (2020-2025)

8 TUBERCULOSIS (TB) DIAGNOSTICS MARKET SALES BY REGION

8.1 Global Tuberculosis (TB) Diagnostics Sales by Region
  8.1.1 Global Tuberculosis (TB) Diagnostics Sales by Region
  8.1.2 Global Tuberculosis (TB) Diagnostics Sales Market Share by Region
8.2 Global Tuberculosis (TB) Diagnostics Market Size by Region
  8.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region
  8.2.2 Global Tuberculosis (TB) Diagnostics Market Size by Region
8.3 North America
  8.3.1 North America Tuberculosis (TB) Diagnostics Sales by Country
  8.3.2 North America Tuberculosis (TB) Diagnostics Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Tuberculosis (TB) Diagnostics Sales by Country
  8.4.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Tuberculosis (TB) Diagnostics Sales by Region
  8.5.2 Asia Pacific Tuberculosis (TB) Diagnostics Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Tuberculosis (TB) Diagnostics Sales by Country
  8.6.2 South America Tuberculosis (TB) Diagnostics Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Tuberculosis (TB) Diagnostics Sales by Region
  8.7.2 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 TUBERCULOSIS (TB) DIAGNOSTICS MARKET PRODUCTION BY REGION

9.1 Global Production of Tuberculosis (TB) Diagnostics by Region(2020-2025)
9.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tuberculosis (TB) Diagnostics Production
  9.4.1 North America Tuberculosis (TB) Diagnostics Production Growth Rate (2020-2025)
  9.4.2 North America Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tuberculosis (TB) Diagnostics Production
  9.5.1 Europe Tuberculosis (TB) Diagnostics Production Growth Rate (2020-2025)
  9.5.2 Europe Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tuberculosis (TB) Diagnostics Production (2020-2025)
  9.6.1 Japan Tuberculosis (TB) Diagnostics Production Growth Rate (2020-2025)
  9.6.2 Japan Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tuberculosis (TB) Diagnostics Production (2020-2025)
  9.7.1 China Tuberculosis (TB) Diagnostics Production Growth Rate (2020-2025)
  9.7.2 China Tuberculosis (TB) Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Danaher
  10.1.1 Danaher Basic Information
  10.1.2 Danaher Tuberculosis (TB) Diagnostics Product Overview
  10.1.3 Danaher Tuberculosis (TB) Diagnostics Product Market Performance
  10.1.4 Danaher Business Overview
  10.1.5 Danaher SWOT Analysis
  10.1.6 Danaher Recent Developments
10.2 Roche
  10.2.1 Roche Basic Information
  10.2.2 Roche Tuberculosis (TB) Diagnostics Product Overview
  10.2.3 Roche Tuberculosis (TB) Diagnostics Product Market Performance
  10.2.4 Roche Business Overview
  10.2.5 Roche SWOT Analysis
  10.2.6 Roche Recent Developments
10.3 Thermo Fisher Scientific
  10.3.1 Thermo Fisher Scientific Basic Information
  10.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Overview
  10.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Market Performance
  10.3.4 Thermo Fisher Scientific Business Overview
  10.3.5 Thermo Fisher Scientific SWOT Analysis
  10.3.6 Thermo Fisher Scientific Recent Developments
10.4 BD
  10.4.1 BD Basic Information
  10.4.2 BD Tuberculosis (TB) Diagnostics Product Overview
  10.4.3 BD Tuberculosis (TB) Diagnostics Product Market Performance
  10.4.4 BD Business Overview
  10.4.5 BD Recent Developments
10.5 Abbott
  10.5.1 Abbott Basic Information
  10.5.2 Abbott Tuberculosis (TB) Diagnostics Product Overview
  10.5.3 Abbott Tuberculosis (TB) Diagnostics Product Market Performance
  10.5.4 Abbott Business Overview
  10.5.5 Abbott Recent Developments
10.6 Hologic
  10.6.1 Hologic Basic Information
  10.6.2 Hologic Tuberculosis (TB) Diagnostics Product Overview
  10.6.3 Hologic Tuberculosis (TB) Diagnostics Product Market Performance
  10.6.4 Hologic Business Overview
  10.6.5 Hologic Recent Developments
10.7 Qiagen
  10.7.1 Qiagen Basic Information
  10.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Overview
  10.7.3 Qiagen Tuberculosis (TB) Diagnostics Product Market Performance
  10.7.4 Qiagen Business Overview
  10.7.5 Qiagen Recent Developments
10.8 BioMerieux
  10.8.1 BioMerieux Basic Information
  10.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Overview
  10.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product Market Performance
  10.8.4 BioMerieux Business Overview
  10.8.5 BioMerieux Recent Developments
10.9 Hain Lifescience
  10.9.1 Hain Lifescience Basic Information
  10.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Overview
  10.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product Market Performance
  10.9.4 Hain Lifescience Business Overview
  10.9.5 Hain Lifescience Recent Developments
10.10 Oxford Immunotec
  10.10.1 Oxford Immunotec Basic Information
  10.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Overview
  10.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Market Performance
  10.10.4 Oxford Immunotec Business Overview
  10.10.5 Oxford Immunotec Recent Developments

11 TUBERCULOSIS (TB) DIAGNOSTICS MARKET FORECAST BY REGION

11.1 Global Tuberculosis (TB) Diagnostics Market Size Forecast
11.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Tuberculosis (TB) Diagnostics Market Size Forecast by Country
  11.2.3 Asia Pacific Tuberculosis (TB) Diagnostics Market Size Forecast by Region
  11.2.4 South America Tuberculosis (TB) Diagnostics Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Tuberculosis (TB) Diagnostics by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Tuberculosis (TB) Diagnostics by Type (2026-2035)
  12.1.2 Global Tuberculosis (TB) Diagnostics Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Tuberculosis (TB) Diagnostics by Type (2026-2035)
12.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Application (2026-2035)
  12.2.1 Global Tuberculosis (TB) Diagnostics Sales (K Units) Forecast by Application
  12.2.2 Global Tuberculosis (TB) Diagnostics Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Tuberculosis (TB) Diagnostics Market Size by Type (M USD)
Table 4. Global Tuberculosis (TB) Diagnostics Market Size by Application
Table 5. Tuberculosis (TB) Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Tuberculosis (TB) Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Tuberculosis (TB) Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Tuberculosis (TB) Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Tuberculosis (TB) Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2025)
Table 11. Global Market Tuberculosis (TB) Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Tuberculosis (TB) Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tuberculosis (TB) Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Tuberculosis (TB) Diagnostics Sales by Type (K Units)
Table 27. Global Tuberculosis (TB) Diagnostics Market Size by Type (M USD)
Table 28. Global Tuberculosis (TB) Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Tuberculosis (TB) Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Tuberculosis (TB) Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)
Table 32. Global Tuberculosis (TB) Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Tuberculosis (TB) Diagnostics Sales (K Units) by Application
Table 34. Global Tuberculosis (TB) Diagnostics Market Size by Application
Table 35. Global Tuberculosis (TB) Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Tuberculosis (TB) Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Table 39. Global Tuberculosis (TB) Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Tuberculosis (TB) Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Tuberculosis (TB) Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)
Table 44. North America Tuberculosis (TB) Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Tuberculosis (TB) Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Tuberculosis (TB) Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Tuberculosis (TB) Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Tuberculosis (TB) Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Tuberculosis (TB) Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Tuberculosis (TB) Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Tuberculosis (TB) Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Tuberculosis (TB) Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Tuberculosis (TB) Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Tuberculosis (TB) Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Tuberculosis (TB) Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Danaher Basic Information
Table 63. Danaher Tuberculosis (TB) Diagnostics Product Overview
Table 64. Danaher Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Danaher Business Overview
Table 66. Danaher SWOT Analysis
Table 67. Danaher Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Tuberculosis (TB) Diagnostics Product Overview
Table 70. Roche Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Thermo Fisher Scientific Basic Information
Table 75. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Overview
Table 76. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific SWOT Analysis
Table 79. Thermo Fisher Scientific Recent Developments
Table 80. BD Basic Information
Table 81. BD Tuberculosis (TB) Diagnostics Product Overview
Table 82. BD Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. BD Business Overview
Table 84. BD Recent Developments
Table 85. Abbott Basic Information
Table 86. Abbott Tuberculosis (TB) Diagnostics Product Overview
Table 87. Abbott Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Abbott Business Overview
Table 89. Abbott Recent Developments
Table 90. Hologic Basic Information
Table 91. Hologic Tuberculosis (TB) Diagnostics Product Overview
Table 92. Hologic Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Hologic Business Overview
Table 94. Hologic Recent Developments
Table 95. Qiagen Basic Information
Table 96. Qiagen Tuberculosis (TB) Diagnostics Product Overview
Table 97. Qiagen Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Qiagen Business Overview
Table 99. Qiagen Recent Developments
Table 100. BioMerieux Basic Information
Table 101. BioMerieux Tuberculosis (TB) Diagnostics Product Overview
Table 102. BioMerieux Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. BioMerieux Business Overview
Table 104. BioMerieux Recent Developments
Table 105. Hain Lifescience Basic Information
Table 106. Hain Lifescience Tuberculosis (TB) Diagnostics Product Overview
Table 107. Hain Lifescience Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Hain Lifescience Business Overview
Table 109. Hain Lifescience Recent Developments
Table 110. Oxford Immunotec Basic Information
Table 111. Oxford Immunotec Tuberculosis (TB) Diagnostics Product Overview
Table 112. Oxford Immunotec Tuberculosis (TB) Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Oxford Immunotec Business Overview
Table 114. Oxford Immunotec Recent Developments
Table 115. Global Tuberculosis (TB) Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Tuberculosis (TB) Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Tuberculosis (TB) Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Tuberculosis (TB) Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Tuberculosis (TB) Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Tuberculosis (TB) Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Tuberculosis (TB) Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Tuberculosis (TB) Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Tuberculosis (TB) Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Tuberculosis (TB) Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Tuberculosis (TB) Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tuberculosis (TB) Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Tuberculosis (TB) Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Tuberculosis (TB) Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tuberculosis (TB) Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tuberculosis (TB) Diagnostics Product Life Cycle
Figure 13. Tuberculosis (TB) Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Tuberculosis (TB) Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Tuberculosis (TB) Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tuberculosis (TB) Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Tuberculosis (TB) Diagnostics
Figure 19. Global Tuberculosis (TB) Diagnostics Market PEST Analysis
Figure 20. Global Tuberculosis (TB) Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tuberculosis (TB) Diagnostics Market Share by Type
Figure 27. Sales Market Share of Tuberculosis (TB) Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Tuberculosis (TB) Diagnostics by Type in 2025
Figure 29. Market Share of Tuberculosis (TB) Diagnostics by Type (2020-2025)
Figure 30. Market Share of Tuberculosis (TB) Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tuberculosis (TB) Diagnostics Market Share by Application
Figure 33. Global Tuberculosis (TB) Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Tuberculosis (TB) Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Tuberculosis (TB) Diagnostics Market Share by Application in 2025
Figure 37. Global Tuberculosis (TB) Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tuberculosis (TB) Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Tuberculosis (TB) Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tuberculosis (TB) Diagnostics Market Size by Country in 2024
Figure 45. U.S. Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tuberculosis (TB) Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Tuberculosis (TB) Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tuberculosis (TB) Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tuberculosis (TB) Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Tuberculosis (TB) Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tuberculosis (TB) Diagnostics Market Size by Country in 2024
Figure 55. Germany Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tuberculosis (TB) Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Tuberculosis (TB) Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tuberculosis (TB) Diagnostics Market Size by Region in 2024
Figure 68. China Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tuberculosis (TB) Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Tuberculosis (TB) Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Tuberculosis (TB) Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Tuberculosis (TB) Diagnostics Market Size by Country in 2024
Figure 82. Brazil Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tuberculosis (TB) Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Tuberculosis (TB) Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tuberculosis (TB) Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tuberculosis (TB) Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tuberculosis (TB) Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Tuberculosis (TB) Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tuberculosis (TB) Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Tuberculosis (TB) Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Tuberculosis (TB) Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Tuberculosis (TB) Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Tuberculosis (TB) Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Tuberculosis (TB) Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Tuberculosis (TB) Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Tuberculosis (TB) Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Tuberculosis (TB) Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Application (2026-2035)


More Publications